We are live on ! Find out more
OBIO icon

Orchestra BioMed
OBIO

44 hedge funds and large institutions have $132M invested in Orchestra BioMed in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60.24% more ownership

Funds ownership: 0% → 60.24% (+60%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.54M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.54M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.98M
4
BlackRock
BlackRock
New York
+$8.98M
5
CAM
Cormorant Asset Management
Massachusetts
+$8.98M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$9.35M +$9.54M +850,000 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$9.35M +$9.54M +850,000 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$8.8M +$8.98M +800,000 New
CAM
4
Cormorant Asset Management
Massachusetts
$8.8M +$8.98M +800,000 New
BlackRock
5
BlackRock
New York
$8.8M +$8.98M +800,000 New
PI
6
Putnam Investments
Massachusetts
$8.25M +$8.42M +750,000 New
RCM
7
RA Capital Management
Massachusetts
$6.88M +$7.02M +625,000 New
O
8
OrbiMed
New York
$5.5M +$5.61M +500,000 New
DKCM
9
Davidson Kempner Capital Management
New York
$4.98M +$5.09M +452,855 New
PA
10
Perceptive Advisors
New York
$4.95M +$5.05M +450,000 New
APM
11
Avidity Partners Management
Texas
$4.4M +$4.49M +400,000 New
BC
12
Boxer Capital
California
$4.4M +$4.49M +400,000 New
EC
13
EcoR1 Capital
California
$4.4M +$4.49M +400,000 New
WP
14
Woodline Partners
California
$4.4M +$4.49M +400,000 New
ACP
15
Acuta Capital Partners
California
$4.32M +$4.41M +392,500 New
LGM
16
Logos Global Management
California
$3.3M +$3.37M +300,000 New
BFM
17
Boothbay Fund Management
New York
$2.83M +$2.89M +257,253 New
PAMP
18
Polar Asset Management Partners
Ontario, Canada
$2.78M +$2.84M +252,500 New
Citadel Advisors
19
Citadel Advisors
Florida
$2.75M +$2.81M +250,000 New
SCM
20
Sio Capital Management
New York
$2.75M +$2.81M +250,000 New
AIC
21
AWM Investment Company
New York
$2.2M +$2.25M +200,000 New
PC
22
Periscope Capital
Ontario, Canada
$2.2M +$2.25M +200,000 New
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$2M +$2.03M +180,771 New
GL
24
Governors Lane
New York
$1.93M +$1.97M +175,000 New
KPF
25
K2 Principal Fund
Ontario, Canada
$1.64M +$1.67M +149,000 New
1
2

OBIO Hedge Fund Activity: Q3 2020 in Review

44 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Orchestra BioMed (OBIO) for Q3 2020, worth a combined $132M.

Buyers outnumbered sellers: 44 funds opened new OBIO positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $9.54M.

  • 44 institutional investors held Orchestra BioMed (OBIO) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $132M of Orchestra BioMed stock for Q3 2020.
  • 44 funds opened new Orchestra BioMed positions in Q3 2020 and 0 closed out, a net change of +44 holders.
  • The largest Orchestra BioMed buyer in Q3 2020 was T. Rowe Price Associates, an estimated $9.54M added.

Based on aggregated 13F filings for Q3 2020.